A pharmaceutical strategy and the research and analysis are two different things. We will have a lot of that information prepared during the life of this government, but the full rollout of a comprehensive pharmaceutical strategy will take a little bit longer.
The Program Review Office has been doing some analysis into the costs and the implementation of distribution of pharmaceuticals through the health care system and they’re going to continue to do that work. Thank you.